Evidence map›Paper›PMID 33008930›Full record

Trial reportJournal of nuclear medicine : official publication, Society of Nuclear Medicine2021

Prognostic Value of 16α-

Shizuka Yamada, Hideaki Tsuyoshi, Makoto Yamamoto, Tetsuya Tsujikawa, Yasushi Kiyono, Hidehiko Okazawa, Yoshio Yoshida

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. SyntheticRSC medicinal chemistry · 2024
    Review
  6. Retrospective analysis of theRadiation oncology (London, England) · 2023
    Article
  7. Annals of nuclear medicine · 2023
    Article
  8. Article
  9. Review
  10. PET Imaging of Estrogen Receptors UsingMethods in molecular biology (Clifton, N.J.) · 2022
    Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shizuka YamadaDepartment of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan; and.
Hideaki TsuyoshiDepartment of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan; and.
Makoto YamamotoDepartment of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan; and.
Tetsuya TsujikawaBiomedical Imaging Research Center, University of Fukui, Fukui, Japan.
Yasushi KiyonoBiomedical Imaging Research Center, University of Fukui, Fukui, Japan.
Hidehiko OkazawaBiomedical Imaging Research Center, University of Fukui, Fukui, Japan.
Yoshio YoshidaDepartment of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan; and yyoshida@u-fukui.ac.jp.
University of Fukui · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study was to evaluate the potential of 16α-

Indexed as

Positron-Emission TomographyAdultAged, 80 and overEndometrial NeoplasmsEstradiolFemaleHumansLymphatic MetastasisMiddle AgedPrognosisProspective Studies16-fluoroestradiolEstradiol16α-18F-fluoro-17β-estradiol (18F-FES)18F-FDGendometrial cancerPET/CTprognostic marker

Identifiers

PMID33008930
PMCPMC8844258
OpenAlexW3089363849

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.